Orifarm

Orifarm Group is a leading European pharmaceutical company headquartered in Odense, Denmark, specializing in parallel imports and the development of generic medicines. Founded in 1994, the company has grown to become the largest supplier of parallel-imported pharmaceuticals in Europe and a significant player in the Nordic generics market. Orifarm's business model focuses on providing high-quality, affordable healthcare products to consumers and healthcare systems by leveraging price differences across EU/EEA markets. In addition to its core import business, the company offers a wide portfolio of prescription generics and over-the-counter (OTC) brands. Following the acquisition of a large portfolio from Takeda in 2020, Orifarm has significantly expanded its presence in the healthcare sector across Northern Europe. The company remains family-owned and continues to emphasize its mission of making healthcare more affordable.